Nebula Research & Development’s Elanco Animal Health ELAN Stock Holding History

Nebula Research & Development’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,835	Closed	-$366K	–	1007
2025 Q1	$366K	Sell	34,835 -127,192	-79%	-$1.44M	0.03%	705
2024 Q4	$1.96M	Buy	162,027 +16,382	+11%	+$214K	0.23%	111
2024 Q3	$2.14M	Buy	+145,645	New	+$2.03M	0.26%	86
2023 Q4	–	Sell	-10,918	Closed	-$123K	–	706
2023 Q3	$123K	Buy	+10,918	New	+$127K	0.06%	440
2023 Q2	–	Sell	-13,670	Closed	-$128K	–	369
2023 Q1	$128K	Buy	+13,670	New	+$161K	0.23%	193

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nebula Research & Development's ELAN Position: Q2 2025 in Review

Nebula Research & Development sold out of Elanco Animal Health (ELAN) in Q2 2025, closing a stake of 34,835 shares — an estimated $366K sold.

Nebula Research & Development first reported a position in ELAN in Q1 2023 and held it in 5 quarters. The position peaked at $2.14M in Q3 2024. 367 funds tracked by Wall St. Rank hold ELAN as of Q2 2025.

Nebula Research & Development reported no remaining Elanco Animal Health position as of Q2 2025 after selling out during the quarter.
Nebula Research & Development sold 34,835 Elanco Animal Health shares in Q2 2025, an estimated $366K.
Nebula Research & Development first reported a position in Elanco Animal Health in Q1 2023 and held it in 5 quarters.
Nebula Research & Development's Elanco Animal Health position peaked at $2.14M in Q3 2024.
367 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2025.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.